OpenVSafe by OpenVAERS
Search V-safe

XX8-26139-62095

2 vaccinations 5 coded responses 25 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
21-25
ZIP prefix
900 / CA
Registered
2021-03-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-05
    Registered in v-safe
  2. 2021-03-05
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-05
    Health check-in — 0 day, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Diarrhea
    Adult check-in
  5. 2021-03-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Diarrhea
    Adult check-in
  6. 2021-03-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  8. 2021-03-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-12
    Health check-in — 7 day, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  11. 2021-03-19
    Health check-in — 14 day, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-26
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-26
    Health check-in — 0 day, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-03-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  15. 2021-03-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  16. 2021-03-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-03-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-03-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-02
    Health check-in — 7 day, dose 2
    Feeling: Good · Headache
    Adult check-in
  21. 2021-04-09
    Health check-in — 14 day, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-16
    Survey response — 21 day, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  23. 2021-04-23
    Survey response — 28 day, dose 2
    MedDRA: Pain — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  24. 2021-04-30
    Survey response — 35 day, dose 2
    MedDRA: Lymphadenopathy, Peripheral swelling — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  25. 2021-05-07
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-25
    Health check-in — 3 month, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-24
    Survey response — 6 month, dose 2
    MedDRA: Arthralgia, Arthritis, Dyspnoea, Muscle spasms, Pruritus, SARS-CoV-2 test negative, Taste disorder — Feeling: Good
    MedDRA releases: 2024-11 · check-in answers available
  28. 2022-03-26
    Survey response — 12 month, dose 2
    MedDRA: Obsessive-compulsive disorder, Peripheral coldness, Poor peripheral circulation, Tinnitus — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11 · check-in answers available
  29. 2022-03-26
    Report sent to call center — 12 month, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  30. 2022-03-29
    Call successful
    Does not wish to fill out VAERS report

Vaccinations

DoseDateManufacturerCo-administered
12021-03-05Pfizer-BioNTech
22021-03-26Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-03-26 Successful
2022-03-29
Does not wish to fill out VAERS report

Free text

Release 7

Symptoms: Collarbone soreness, maybe lymph nodes swollen

Symptoms: Sore collarbones.

Release 8

Symptoms: Swollen lymph nodes near arm pits, collarbones, and inner thigh. Dry cough.

Release 9

Symptoms: Shortness of breath and throat muscle spasms (multiple negative Covid tests), neck joint pain, inflamed joints, itchiness, altered tasting ability that lasts for only a few hours and comes and goes.

Release 11

Symptoms: Problems with circulation resulting in abnormally cold extremities; pulsative tinnitus; OCD;

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArthralgia · · ✓
SDArthritis · · ✓
SDDyspnoea · · ✓
SDLymphadenopathy ✓ ✓ ✓
SDMuscle spasms · · ✓
SDObsessive-compulsive disorder · · ✓
SDPain ✓ ✓ ✓
SDPeripheral coldness · · ✓
SDPeripheral swelling ✓ ✓ ✓
SDPoor peripheral circulation · · ✓
SDPruritus · · ✓
SDSARS-CoV-2 test negative · · ✓
SDTaste disorder · · ✓
SDTinnitus · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release